Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
In July 2024, a retrospective study on overweight or obese adults treated for type 2 diabetes, 81.8% of people receiving tirzepatide (Mounjaro) lost at least 5% of their weight within one year compared to 66.5% of those using semaglutide (Ozempic), a significant difference (which means it did not just happen by chance)
BPC-157: The Injury Recovery Breakthrough If there's one peptide that has captured the attention of athletes, coaches, and injury specialists in 2026, it's BPC-157
These findings help reveal the metabolic, cardiovascular, and psychological effects of L-carnitine supplementation, shedding light on its potential benefits for athletes in high-intensity endurance sports
You should not use this medication if you have heart disease, hyperthyroidism, glaucoma, or severe kidney or liver disease or if youre pregnant or nursing
The STEP program trials with semaglutide (a GLP-1-only agonist) and the SURMOUNT trials with tirzepatide (dual GIP/GLP-1 agonist) represent the strongest weight loss efficacy data in the history of pharmacotherapy for obesity
Laboratory Testing to Guide Treatment Decisions Lab tests are vital for making B12 treatment plans
